Group 3
Plan
Team
Partners
Stories
News & Updates
Contact Us
Contact Us
Menu
News & Updates
All
News
Press Release
07/12/23
Press Release
SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
View Article
04/19/23
Press Release
SOLVE FSHD invests in Epic Bio for the development of a novel treatment for Facioscapulohumeral Muscular Dystrophy
View Article
10/15/22
Press Release
SOLVE FSHD Invests Up To US $10 Million in Vita Therapeutics
View Article
10/12/22
Press Release
SOLVE FSHD Invests US $1 Million in miRecule to Accelerate Development of Best-in-Class Antibody-RNA Conjugate to Treat Facioscapulohumeral Muscular Dystrophy
View Article
09/22/22
Press Release
SOLVE FSHD Invests US$3 Million in Altay Therapeutics
View Article
03/11/22
Press Release
SOLVE FSHD is supporting the FSHD Clinical Trial Research Network (CTRN) through a donation of $2.8M to the FSHD Canada Foundation
fshd.ca
03/09/22
Press Release
SOLVE FSHD Supports the FSHD Canada Foundation in Funding of US$1.2M in Multidisciplinary Biomarker Grants
View Article
Press Release